argenx (ARGX) news
Recent news
Argenx: UBS cuts target price to $1300 from $1400
AInvest Wire · 9h agoArgenx SE shares up 4.7%
Argenx SE (NASDAQ: ARGX) shares rose 4.7% on October 9, 2026, following continued momentum in the biotechnology sector and positive investor sentiment surrounding the company’s commercial performance. The stock is currently trading at $818.63, with a 52-week range of $661.85 to $1,072.75. The…
AInvest Wire · 6d agoArgenx SE: JEFFERIES cuts target price to $1,200 from $1,235
Argenx SE (Euronext: ARGX) has seen a recent adjustment in its price target by Jefferies, a prominent investment bank. The firm revised its target price for the biopharmaceutical company from $1,235 to $1,200, reflecting a slight downward revision in its valuation expectations. This adjustment,…
AInvest Wire · 6d agoArgenx SE: Baird cuts target price to $823 from $932
AInvest Wire · 7d agoArgenx SE: KBC Securities cuts target price to EUR 950 from EUR 1000; rating buy
KBC Securities has revised its target price for Argenx SE (ARGX) to EUR 950 from EUR 1,000, while maintaining its "buy" rating for the biotechnology company. The adjustment reflects updated financial modeling and ongoing evaluation of the firm’s pipeline and market dynamics. Argenx continues to…
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.